glp-1 and dual glp-1/gip receptor agonists Major physiological roles of GIP. Tirzepatide is acting as an Oral GLP-1-Based Therapeutics in the
Description
Type 2 diabetes and GLP-1 RA treatment response It is also important to note that therapeutic responses may differ between patients with and without T2DM, a difference likely driven by several interrelated mechanisms [42]

Three factor eating questionnaire-R18 as a measure of cognitive restraint, uncontrolled eating and emotional eating in a sample of young Finnish females

If Phase 3 trials confirm these results, retatrutide could significantly shift the treatment paradigm

Fixed-ratio combination therapy for type 2 diabetes: the top ten things you should know about insulin and glucagon-like peptide-1 receptor agonist combinations

Bone, body weight, and weight reduction: what are the concerns
